Fig. 5
From: Cytosolic phospholipase A2 as a therapeutic target for degenerative joint diseases
Deletion of cPLA2 protects against age-associated OA. a Safranin O/Fast Green, and H&E staining in knee joint section collected from WT and cPLA2 KO male mice at age 18 months. Scale bar = 100 µm. b Quantitation of the cartilage thickness, SBP thickness and the composition of the articular cartilage of WT and cPLA2 KO male mice based on HE staining (green: cartilage; red: bone). (n = 6). c Safranin O/Fast Green, and H&E staining in knee joint section collected from WT and cPLA2 KO female mice at age 18 months. Scale bar = 100 µm. d Quantitation of the cartilage thickness, SBP thickness and the composition of the articular cartilage of WT and cPLA2 KO female mice based on HE staining (green: cartilage; red: bone). (n = 6). b, d Data are mean±s.d., P-values by two-tailed unpaired Student’s t-test
